Catalent Partners with Siren Biotechnology in Pioneering Cancer Gene Therapy
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, and Catalent Inc., recently acquired by Novo Holdings, have announced a strategic partnership. The collaboration is…